In both B16 melanoma and CT26 colon tumor models, combinatorial treatment with anti-VISTA and anti-PD-L1 mAbs resulted in tumor regression and long-term survival in comparison to monotherapies (103, 104). Here, CD274 is linked to colonic neoplasm.